Entry |
|
Name |
Bivalirudin (USAN/INN) |
Formula |
C98H138N24O33
|
Exact mass |
2178.9858
|
Mol weight |
2180.2853
|
Sequence |
FPRPGGGGNG DFEEIPEEYL |
Type |
Peptide |
Class |
|
Remark |
Product (DG02963): | D11280<US> |
|
Efficacy |
Anticoagulant, Thrombin inhibitor |
Comment |
Peptide
Hirudin derivative
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
hsa04610 | Complement and coagulation cascades |
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AE Direct thrombin inhibitors
B01AE06 Bivalirudin
D03136 Bivalirudin (USAN/INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Serine peptidases
F2
D03136 Bivalirudin (USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03136
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03136
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03136
|
Other DBs |
|
LinkDB |
|